Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine.
Xintao HuKrithika P KarthigeyanSavannah HerbekSarah M ValenciaJennifer A JenksHelen WebsterItzayana G MillerMegan ConnorsJustin PollaraCaroline AndyLinda M GerberEmmanuel B WalterKathryn M EdwardsDavid I BernsteinJacob HouMatthew KochLori PantherAndrea CarfiKai WuSallie R PermarPublished in: The Journal of infectious diseases (2024)
NCT03382405 (mRNA-1647) and NCT00133497 (gB/MF59).